GGrantIndex
Sort

11,323 grants matching glioblastoma

SPORE in Brain Cancer

$2,171,252
Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2025 · CA

Signal Processing And Instrumentation Section

$2,170,499
Thomas J Pohida · Center For Information Technology · ZIA · FY2021 · CT

Experimental Therapy for Brain Tumors

$2,170,371
John H Sampson · Duke University · P01 · FY2018 · CA

Imaging and Tissue Correlates to Optimize Management of Glioblastoma

$2,170,035
Susan M Chang · University Of California, San Francisco · P01 · FY2016 · CA

p53, Aging, and Cancer

$2,168,979
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

SPORE: Targeted Therapies for Glioma

$2,166,955
Tracy T Batchelor · Massachusetts General Hospital · P50 · FY2015 · CA

Genetics and Biology of Malignant Glioma

$2,165,799
Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2010 · CA

Molecular Diagnostics Core Laboratory

$2,164,058
Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA

Brain Tumor Clinical and Clinical Research Program

$2,162,361
Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2017 · CA

Developmental and HyperActive Ras Tumor SPORE

$2,162,000
David W. Clapp · Indiana University Indianapolis · U54 · FY2016 · CA

SPORE: Targeted Therapies for Glioma

$2,162,000
Tracy T Batchelor · Massachusetts General Hospital · P50 · FY2016 · CA

Duke SPORE in Brain Cancer

$2,162,000
John H Sampson · Duke University · P50 · FY2014 · CA

Mayo SPORE in Brain Cancer

$2,161,746
Brian Patrick O'Neill · Mayo Clinic Rochester · P50 · FY2011 · CA

UCLA SPORE in Brain Cancer

$2,161,493
Linda M Liau · University Of California Los Angeles · P50 · FY2025 · CA

Mayo SPORE in Brain Cancer

$2,158,823
Brian Patrick O'Neill · Mayo Clinic Rochester · P50 · FY2015 · CA

Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma

$2,157,708
Susan M Chang · University Of California, San Francisco · P01 · FY2019 · CA

Sex-based Differences in Glioma

$2,156,584
Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · P01 · FY2020 · CA

Integrative Pathophysiology of Solid Tumors

$2,155,490
Rakesh K. Jain · Massachusetts General Hospital · P01 · FY2013 · CA

MIT/Mayo Physical Sciences Center for Drug Distribution and Efficacy in Brain Tumors

$2,152,225
Forest M White · Massachusetts Institute Of Technology · U54 · FY2016 · CA

Lentiviral-MGMT gene transfer into hematopoietic stem cells

$2,150,576
Stanton L Gerson · Lentigen Corporation · R42 · FY2011 · CA

SPORE: Targeted Therapies for Glioma

$2,150,500
Tracy T Batchelor · Massachusetts General Hospital · P50 · FY2013 · CA

Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs

$2,149,233
Peter Karl Sorger · Harvard Medical School · U54 · FY2020 · CA

Mayo SPORE in Brain Cancer

$2,147,799
Brian Patrick O'Neill · Mayo Clinic Rochester · P50 · FY2007 · CA

SPORE: Targeted Therapies for Glioma

$2,144,141
Tracy T Batchelor · Massachusetts General Hospital · P50 · FY2014 · CA

SPORE for Translational Approaches to Brain Cancer

$2,140,963
Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2025 · CA